Drug factory · FDA FEI 3003444315

Aptuit (Oxford) Ltd

Building 111, Innovation Drive, Milton Park, Milton, Abingdon, United Kingdom

United Kingdom: 1

Problems found, fixed voluntarily at FDA's last inspection, Aug 22, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

4 drug inspections on record since 2013: 0 with no problems, 4 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
PlerixaforMakes the active ingredient and tests it Sanofi-Aventis U.S. LLC 0024-5862

FDA inspection history

EndedResultProgramProblems noted
Aug 22, 2025Problems found, fixed voluntarilyDrug Quality Assurance—
Nov 16, 2018Problems found, fixed voluntarilyDrug Quality Assurance—
Jul 22, 2016Problems found, fixed voluntarilyDrug Quality Assurance—
Sep 13, 2013Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture.